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Over the last several decades, procedures performed in the pediatric and congenital cardiac catheterization 
laboratory (PCCCL) for children and adults with congenital heart disease (CHD) or children with 
acquired heart disease have transitioned from being primarily diagnostic to interventional and therapeutic. 
However, with the advanced therapeutic options for patients with CHD comes the increased risk of 
adverse events. Adverse events related to pediatric cardiac catheterization have been reported in 4%–10% 
of procedures. Although most adverse events are not associated with mortality, they can occur suddenly 
and unexpectedly [1–5]. Along with the increase in patient and procedure complexity, there has been a 
more detailed delineation of sedation policies both at the institutional and the national level (e.g., the 
American Academy of Pediatrics (AAP) and The Joint Commission). It is therefore imperative that 
personnel with the skill sets necessary to anticipate, prevent, and treat complications related to the 
catheterization procedure and sedation/anesthesia be in attendance.  
Because the current practice of sedation and anesthesia for patients undergoing PCCCL procedures is 
known to vary among institutions, a multi-society expert panel with representatives from the Congenital 
Heart Disease Council of the Society for Cardiovascular Angiography and Interventions (SCAI), the 
Society for Pediatric Anesthesia (SPA) and the Congenital Cardiac Anesthesia Society (CCAS) was 
convened to evaluate the types of sedation and personnel necessary for procedures performed in the 
PCCCL. The goal of this panel was to provide practitioners and institutions performing these procedures 
with guidance consistent with national standards and to provide clinicians and institutions with 
consensus-based recommendations and the supporting references to encourage their application in quality 
improvement programs. This task is difficult because the patients cared for vary widely in age, ranging 
from premature infants to adults, from simple to complex in physiology, and ranging in cooperation 
ability: from those who cannot cooperate or are combative and might need general anesthesia to those 
who are fully cooperative and might need little or no sedation. Recommendations can neither encompass 
all clinical circumstances nor replace the judgment of individual clinicians in the management of each 
patient. The science of medicine is rooted in evidence, and the art of medicine is based on the application 
of this evidence to the individual patient. This expert consensus statement has adhered to these principles 
for optimal management of patients requiring sedation and anesthesia. What follows are 
recommendations for patient monitoring in the PCCCL regardless of whether minimal or no sedation is 
being used or general anesthesia is being provided by an anesthesiologist. 
Complications and Risks  
Factors contributing to adverse events in the PCCCL are multi-factorial in origin and can be patient, 
practitioner and/or procedure-related. Although it might not be possible to attribute an event to a specific 
cause, we will discuss procedural risks based on an overview of the current literature.  
Anesthesia Risks in Patients with Cardiac Disease Undergoing Surgery and Procedures in the 
PCCCL 
Studies concerning anesthesia-related morbidity and mortality in recent decades have demonstrated that 
pediatric patients and especially patients with CHD are at increased risk for adverse events and cardiac 
arrest during surgery [1–3]. Common complications in children undergoing sedation or general anesthesia 
include airway events (laryngospasm, bronchospasm, apnea and aspiration), cardiovascular events 
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(hypotension, arrhythmias and cardiac arrest) and postoperative issues such as nausea and vomiting, 
emergence agitation, hypoxemia and apnea. In a prospective quality assurance audit of 24,165 anesthetics 
in children undergoing surgery, Murat et al. showed that respiratory issues comprised 53% and cardiac 
issues 12.5% of intraoperative adverse events [4]. Respiratory events were more common in infants under 
one year of age, intubated patients and those who were American Society of Anesthesiologists Physical 
Status (ASA PS) 3 or 4. Cardiac events were also most common in those with ASA PS 3 or 4. Similarly, 
in 2006, Braz et al. studied 15,253 anesthetics in children and found the risk factors for adverse events to 
be an age <1 year, an ASA PS of 3 or 4, emergency procedures and preoperative intubation [5]. Patients 
with CHD undergoing cardiac catheterization typically have a higher ASA physical status and therefore 
are at increased risk even before the catheterization procedure has started.  
Flick et al. found that in 92,881 anesthetics the cardiac arrest rate was 2.9/10,000 in children undergoing 
noncardiac surgery and 127/10,000 in cardiac surgical procedures, with a mortality rate of 1.6/10,000 [3]. 
Eighty-eight percent of those who experienced a cardiac arrest had CHD. The rate of cardiac arrest was 
highest in neonates undergoing cardiac surgery at 435/10,000 and mortality at 389/10,000. 
Vitiello et al. found that patient age and interventional catheterization procedures were risk factors for 
morbidity and mortality in the PCCCL [6]. The specific risk factors for anesthesia and sedation were 
young age, low weight and need for intubation. Bennet et al. examined adverse events in the cardiac 
catheterization lab specifically from an anesthetic perspective and found in 4454 catheterizations an 
adverse event rate of 9.3% for diagnostic procedures and 11.6% for interventional procedures [7]. There 
were 90 incidents; 33 were respiratory, of which 20 were airway events, and 22 were cardiovascular 
events, of which 17 were transient arrhythmias. The mortality rate (4 deaths) was 0.08%. All the deaths 
were in patients under 18 months of age. Adverse events occurred most frequently in patients <1 year of 
age and in those having interventional procedures other than persistent ductus arteriosus (PDA) and atrial 
septal defect (ASD) closure. These rates of adverse events are similar to those published in the IMPACT 
(Improving Pediatric and Adult Congenital Treatment) Registry in nearly 20,000 patients, with adverse 
events occurring in 10% of diagnostic and 11.1% of interventional procedures [8].  
The Pediatric Perioperative Cardiac Arrest (POCA) Registry collected data on 373 anesthesia-related 
cardiac arrests in children, 34% of whom had congenital or acquired heart disease [2]. Of the patients 
with heart disease, anesthesia-related cardiac arrests occurred 54% of the time in the general pediatric 
OR, 26% in the cardiac OR and 17% in the PCCCL. Fifty-nine percent of patients with uncorrected and 
26% with palliated single-ventricle physiology had the highest risk of cardiac arrest, whereas patients 
with aortic stenosis or cardiomyopathy had the highest risk of mortality following a cardiac arrest, at 62% 
and 50%, respectively. These lesions accounted for more than 75% of all deaths reported to the POCA 
registry. Nearly half (47%) of cardiac arrests in children with heart disease occurred in those younger than 
6 months of age.  
Specific Cardiac Defects with Increased Anesthetic Risks  
Several diagnoses merit mention due to their increased risks for complications during cardiac 
catheterization. The Risk Adjustment for Congenital Heart Surgery (RACHS) places stage I palliation of 
hypoplastic left heart syndrome (HLHS) in the highest risk category for perioperative complications 
following cardiac surgery [9]. Torres et al. reported a 19% mortality rate for non-cardiac surgery in 
children younger than 2 years of age with HLHS [10]. Induction instability was associated with 
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procedures performed prior to cavopulmonary anastomosis (Glenn procedure). Myocardial ischemia and 
cardiac arrest can occur suddenly in patients with single-ventricle physiology after induction of anesthesia 
and introduction of positive pressure ventilation. Reduced coronary perfusion pressure might be an 
important contributing factor and might be caused by a decrease in preload and a reduction in aortic root 
pressure if pulmonary vascular resistance decreases and pulmonary runoff increases, thereby decreasing 
systemic perfusion. Subendocardial perfusion is particularly tenuous if diastolic perfusion time is reduced 
by concomitant tachycardia. These patients also have a limited ability to increase coronary blood flow 
when myocardial oxygen demand is increased, for example with increased contractility or wall stress in 
response to an increased stimulus from an inadequate depth of anesthesia [11–13].  
Pulmonary arterial hypertension is associated with an increased risk of perioperative cardiovascular 
complications. Carmosino et al. retrospectively reviewed children with pulmonary hypertension who 
underwent anesthesia for sedation for noncardiac surgery or cardiac catheterization [14]. Cardiac arrest 
and pulmonary hypertensive crises occurred in 4.5% of the children undergoing noncardiac surgery and 
5.0% of the children undergoing cardiac catheterization. Major complications were predicted by 
suprasystemic pulmonary artery pressure, but were independent of patient age and the etiology of the 
pulmonary artery hypertension. A recent study on postoperative mortality in children identified 10 cases 
with preexisting medical conditions as a significant risk factor, with five of these patients having 
pulmonary hypertension [15]. Pulmonary hypertension causes right ventricle hypertension and 
hypertrophy, and induction of anesthesia with positive pressure ventilation further decreases the preload 
and increases the afterload on the right ventricle, causing the right ventricle to fall off the Starling curve 
and fail. These patients are almost impossible to resuscitate due to a lack of pulmonary blood flow 
secondary to increased pulmonary vascular resistance (PVR) and pulmonary artery pressure, leading to 
lack of venous return to the left heart and low cardiac output. In this patient population, it is important to 
maintain preload, potentially to start inotropic support prior to induction and to have inhaled nitric oxide 
(iNO) available to prevent or treat a pulmonary hypertensive crisis or cardiac arrest. Often, the baseline 
status of the patient is not achieved immediately following the procedure (particularly if the vascular 
resistance has been manipulated with iNO or other medications), and special attention to the patient post 
procedure is required until the patient returns to baseline. 
Patients with left ventricular outflow tract (LVOT) obstruction have unique anesthetic implications. 
Williams-Beuren Syndrome patients with congenital supravalvular aortic stenosis with or without 
associated pulmonary stenosis and right ventricular pressure overload and hypertrophy are at increased 
risk for cardiac arrest when undergoing general anesthesia. These patients might develop coronary 
ischemia secondary to coronary artery abnormalities, including coronary ostial stenosis, despite being 
potentially asymptomatic. In patients with LVOT obstruction including aortic stenosis and hypertrophic 
cardiomyopathy with severe left ventricle hypertrophy, it is important to maintain diastolic pressure and 
coronary perfusion and to avoid tachycardia and ischemia [16]. Patients who have had a cardiac transplant 
are at increased risk of ventricular fibrillation during coronary angiography due to the risk of coronary 
artery disease in this population, as are patients with pulmonary atresia and RV-dependent coronary 
circulation.  
Although most of these studies are limited by their retrospective nature, they identify significant risk 
factors for anesthesia in children, including an age younger than one year, a high ASA PS, a need for 
intubation and unrepaired or palliated cardiac lesions. Studies attempting to discern the causes of adverse 
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events have implicated anesthesia as a causative factor in a small percentage of cases. However, it is clear 
that anesthesia is associated with risks distinct from those related to the procedures themselves. The 
combination of these risks with the inherent risks of caring for pediatric patients with heart disease who 
might have severe alterations in cardiac physiology and function make it crucial to carefully consider the 
strategies and goals of management for each patient on an individual basis. Table 1 lists some of the 
common pati nt types and specific procedures at high risk for anesthesia-related complications. 
Catheterization and Procedural Risks in the Catheterization Laboratory 
The Congenital Cardiac Catheterization Outcomes Project (C3PO), using a strategy based on the 
congenital heart disease adjustment for risk method (CHARM), captured information from 8905 
catheterization procedures over a three-year period from 2007 to 2010 at eight institutions with the goal of 
developing outcome assessment tools for cardiac catheterization procedures (17,18). The procedure risk 
types were grouped into four categories and diagnosis risk types were categorized into five categories 
[17]. Age younger than 1 year, recent cardiac surgery in the past 30 days, hemodynamic vulnerability, 
highest procedure risk group, transfer on ECMO support and longer case duration were risk factors for 
severe adverse events [18]. The risk of adverse events during cardiac catheterization of infants not only 
increases with lower age but also with weight less than 2 kg.  
Odegard et al. retrospectively determined the risks of cardiac arrest in children with CHD in over 7289 
cardiac catheterizations [19]. The risk of cardiac arrests was 0.96%, with a higher risk in children 
undergoing interventional procedures and in children younger than 1 year of age. The risk of cardiac 
arrests based on procedure type included device closure of a ventricular septal defect (11.9 per 100 
procedures), intervention for intact atrial septum or restricted atrial septal flow (10.0 per 100 procedure), 
mitral valve balloon dilation (5.0 per 100 procedures), pulmonary vein dilations (3.6 per 100 procedures) 
and pulmonary artery balloon dilations (0.6 per 100 procedures). The higher risk of cardiac arrest in these 
patient populations is not surprising and should be anticipated. The risk is primarily related to the 
technical aspects of the procedure itself, including the pro-arrhythmogenic effect of stiff wires and 
catheters passing across the muscular septum and the low cardiac output resulting from stenting open 
semilunar and atrioventricular valves. There is also the risk of pulmonary reperfusion injury and 
pulmonary edema following pulmonary artery dilation. This complication might not be immediately 
apparent and careful post-procedure evaluation is necessary, in a similar manner as with the surveillance 
of pulmonary hypertension patients following their procedures. Newborns with single-ventricle 
physiology and a restrictive atrial communication can have a small left atrium, severe left atrial 
hypertension and can be in a low cardiac output state with severe hypoxemia at the time of the 
intervention. The risk of an inadvertent perforation causes these patients to be at increased risk for a 
cardiac arrest during the atrial septal opening procedure. Patients undergoing mitral valve balloon dilation 
to treat valvular stenosis also have left atrial hypertension and are at risk for arrhythmias and decreased 
cardiac output during balloon inflation, thus predisposing them to cardiac arrest.  
 
Data from the IMPACT registry demonstrates that the rate of adverse events for diagnostic or 
interventional procedures is greatest in neonates (30.9% and 30.2% for diagnostic vs. interventional 
procedures, respectively) [8]. These data have not been broken down into weight categories, but we 
suspect that smaller and more premature newborns are likely at greater risk of complications than their 
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older and larger counterparts for any given procedure. Following neonates, infants (≥30 days, <1 year) 
have the next highest risk of adverse events (26.3% and 20.8%, respectively). Children (≥1 year, ≤18 
years) have a risk of 5.5% and 7.3% for adverse events, respectively, whereas adult patients with 
congenital heart disease (>18 years) have a risk of 6.3% and 9.0%, respectively, for adverse events. When 
interventions are further stratified into one of six specific procedures captured in the IMPACT Registry 
(ASD and PDA occlusion, aortic and pulmonary valvuloplasty, angioplasty and stenting of aortic 
coarctation, and proximal pulmonary artery stenting), there are differences between groups with major 
adverse events (MAE) ranging from 0% in pulmonary valvuloplasty to 3.3% in aortic valvuloplasty and 
any adverse event occurring with a range of 4.7% in PDA occlusion, to 22.3% in balloon aortic 
valvuloplasty [20]. Holzer et al. reviewed the adverse event rate in the same cohort of patients undergoing 
interventions other than the six procedures cited above and found a similar spread of adverse events 
depending on the specific procedure. Pulmonary vein and Sano shunt interventions had the highest rate of 
adverse events at 25.3% and 37.5%, respectively [21]. 
A risk model is currently being applied to data from the IMPACT registry. After multivariable 
adjustment, eight variables were identified as critical for risk standardization: patient age, renal 
insufficiency, single-ventricle physiology, procedure-type risk group, low systemic saturation, low mixed 
venous saturation, elevated systemic ventricular end diastolic pressure and elevated main pulmonary 
artery mean pressure. The model had good discrimination (C-statistic of 0.70), confirmed by bootstrap 
validation (validation C-statistic of 0.69) [22]. 
It is clear that children with complex congenital heart disease are at increased risk during catheterization 
procedures of adverse events related not only to the procedure type but also to the underlying diagnosis 
and hemodynamic state. Although there are multiple publications addressing the management of children 
with CHD, there is no established methodology to address the magnitude of incremental risk conferred by 
the degree and severity and compensation of the heart disease. Identification of high-risk patient types 
presenting for cardiac catheterization must be extrapolated from retrospective studies across multiple 
disciplines, including cardiology, cardiac anesthesiology, pediatric anesthesiology and cardiac surgery.  
Anesthesia 
There is no specific anesthetic method that is appropriate for all patients with CHD in the PCCCL as long 
as the sedation provider or anesthesiologist understands the risks, the underlying pathophysiology and the 
impact of the sedation or anesthetic strategy on the hemodynamic status of the patient. 
Volume Management 
Attention to detail regarding the intravascular volume and hematocrit in patients with congenital heart 
disease is imperative during cardiac catheterizations, and physiologic alterations should be promptly 
addressed. 
Hypovolemia might be present at the start of the procedure, particularly in small infants and children, 
secondary to dehydration occurring during prolonged periods of preoperative fasting (NPO). 
Hypovolemia is particularly important in very young, cyanotic, erythrocytotic or shunt-dependent 
patients. In these circumstances it is preferable to administer intravenous isotonic fluids to maintain 
hydration during the fasting period prior to catheterization. Hypovolemia can also occur acutely 
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secondary to massive blood loss. In that setting, normal saline, packed red blood cells, whole blood or 5% 
albumin can be administered to expand the intravascular blood volume while the cause of the bleeding is 
addressed. Careful attention to blood loss is particularly important in neonates who have a small blood 
volume and in cyanotic patients accustomed to an increased hematocrit.  
Volume overload can occur during longer procedures, particularly those involving multiple angiograms, 
and is less tolerated in patients with congestive heart failure or shunt lesions. Acutely, this overload can 
lead to increased filling pressures, pulmonary edema and decreased ventricular function. Judicious use of 
flush solution administered to the patient with impaired reserves or to smaller patients is imperative to 
avoid iatrogenic hypervolemia. Any volume load (saline or blood transfusion) during a hemodynamic 
catheterization procedure needs to be performed with caution and communicated to the invasive 
cardiologist due to possible acute changes in filling pressures. The effect of changing hemoglobin 
concentrations on the calculations of cardiac output and vascular resistance must also be considered, as 
this affects hemodynamic measurements. 
Some assessment of baseline hemoglobin or hematocrit should be performed either before or shortly after 
the start of the procedure or the introduction of an IV or sheath.  
Erythrocytosis (HCT greater than 65%) occurs in cyanotic patients and is particularly common in the 
older cyanotic patient. While erythrocytosis increases oxygen carrying capacity, its higher viscosity 
reduces flow through the microcirculation, leading to decreasing cardiac output, increased pulmonary and 
systemic vascular resistance and a higher risk of thrombosis and emboli. If required, this erythrocytosis 
can be treated in the catheterization laboratory with phlebotomy, which includes replacing the blood 
withdrawn with either isotonic crystalloids or 5% albumin. At the other extreme, anemia decreases the 
oxygen carrying capacity of the blood, leading to increased cardiac output, elevation of trans-stenotic 
pressure gradients and exacerbation of congestive heart failure. Patients with cyanotic or single 
ventricular congenital heart disease, or those with moderate to severe myocardial dysfunction, benefit 
from the improved oxygen-carrying capacity of a hematocrit greater than 40%, whereas patients with 
excellent myocardial function can tolerate hematocrits as low as 25% without difficulty. Preexisting 
anemia is usually exacerbated during a cardiac catheterization by anticipated blood loss during sampling 
for oxygen saturations, blood gas determinations or clotting studies, as well as inadvertent blood loss 
occurring in vascular puncture sites, around catheters and wires and during sheath and catheter exchanges. 
Significant anemia should be identified and corrected prior to the catheterization procedure.  
Effect of the Ventilation Strategy on Physiologic Measurements in the Cardiac Catheterization 
Laboratory 
There is no preferred ventilation strategy in the cardiac catheterization laboratory. General anesthesia with 
positive pressure ventilation provides a secure airway and control of PaCO2, but increased intrathoracic 
pressure may alter hemodynamic measurements. Spontaneous ventilation might maintain more natural 
intrathoracic physiology and consequentially can result in the acquisition of more accurate hemodynamic 
data. However, oversedation can cause airway obstruction, hypoventilation and subsequent respiratory 
acidosis. This increases pulmonary vascular resistance and might alter shunt physiology and affect 
hemodynamic measurements [23,24].  
During spontaneous ventilation, reduced intrathoracic pressure with inspiration facilitates venous return 
and right ventricular output, but afterload on the left ventricle is elevated, causing decreased left 
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ventricular cardiac output. The overall effect on cardiac output is minimal. During controlled ventilation, 
positive intrathoracic pressure causes IVC compression, reducing venous return and preload. The reduced 
preload causes a reduction in pulmonary blood flow and, subsequently, in cardiac output. These 
reductions are particularly pronounced in patients with right heart failure, hypovolemia, or Fontan 
physiology. Although this outcome should be taken into consideration, particularly in pulmonary 
hypertensive patients, studies have demonstrated no difference in complication rates between general 
anesthesia and sedation in pulmonary hypertension patients undergoing cardiac catheterization [25].   
Children with CHD can also have alterations in lung function. Extrinsic compression of conducting 
airways by enlarged atria and pulmonary arteries can cause decreased lung compliance and increased 
airway resistance [28]. Controlled ventilation can have variable effects on these patients.  
The individual patient and clinical situation should be considered when developing an anesthetic plan and 
selecting a ventilation technique. Regardless of the technique, patients having even minimal sedation 
should have their airway and EtCO2 monitored throughout the procedure. 
 
Fostering an Environment of Partnership in Decision Making for Optimal Patient Care, Open 
Communication and Coordination Between Cardiologists and Anesthesiologists 
 
First and foremost, patient care is about patient safety and achieving the desired outcome. In a multi-
professional procedure, optimal outcomes are best accomplished by face-to-face/personal interactions 
between team members. Interventional cardiologists, anesthesiologists and surgeons (for hybrid 
procedures) must spend time discussing the procedure, risks and strategies prior to the procedure taking 
place, especially for high-risk procedures. It is important to consider all viewpoints, including whether the 
procedure is truly necessary before undertaking it. Anesthesiologists and cardiologists must have the 
ability to work effectively with each other as well as with the cardiac catheterization team, and when 
instituting ECMO or during hybrid procedures with the operating and surgical team. The development of 
small,  expert teams that promote the optimization of individual performance and enhanced 
communication should be the ultimate goal. Cardiologists and anesthesiologists should value the 
importance of divergent perspectives because group expertise often trumps individual expertise. In so 
doing, leadership in the catheterization lab should be fluid. The decision maker can change during the 
case, depending on the patient’s status and the situation requiring a decision. Finally, each specialty 
should appreciate the constraints of the other’s work environment.  
 
Periprocedural checklists, (similar to perioperative checklists used in surgery) have become increasingly 
routine, with the goal of improving outcomes and reducing adverse events. These checklists are meant to 
improve intraoperative management and communication and to facilitate postprocedural handoffs 
between units and providers. These checklists might include the lists below.  
 
Preprocedure 
1. Patient identification, diagnosis, intended procedure, documentation of a history and physical 
examination and a signed consent form. 
2. Documentation of allergies, including drug, food, latex and contrast.  
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3. Airway assessment.  
4. Verified NPO status.  
5. Confirmed plan for patient monitoring. 
6. Room setup including the need for transesophageal echocardiography (TEE), iNO, and 
rotational angiography.  
7. Special medications required, including but not limited to antibiotics, antiarrhythmics, 
anticoagulants, vasopressors, stress-dose steroids. 
8. Availability of implanted devices, including pacemakers and implantable cardioverter 
defibrillators. 
9. Bleeding risks, including the presence of a type and screen or crossmatch and the need for 
immediate blood in the catheterization laboratory.  
10. Anesthesia plan (general anesthesia versus monitored anesthesia care [MAC] with 
spontaneous ventilation). 
11. Consideration of the need for ECMO support and surgical backup. 
12. Access plan, sheath size and previous access issues. 
13. Plan for postoperative recovery; home, regular floor or ICU. 
14. Pregnancy test as necessary. 
 
Intraprocedure 
1. Patient identification, diagnosis, and procedure.  
2. Allergies, including drug, food, latex, and contrast.  
3. Antibiotic requirements. 
4. Heparin plan. 
5. Blood availability.  
6. Availability of vasopressor medications and resuscitation equipment. 
7. Disposition postprocedure (inpatient unit, intermediate-care unit, or intensive-care unit).  
 
Postprocedure 
1. Adverse events. 
2. Equipment issues.  
3. Specimens labeled and sent.  
3. Detailed sign-out to floor, intermediate-care unit, intensive-care unit, or PACU.  
4. Necessary postprocedure tests, including echocardiogram, X-ray, or EKG.  
5. Necessary postoperative medications, including but not limited to antiarrhythmics,  
  vasopressors, iNO, and anticoagulation, antiemetics and intravenous fluid therapy. 
6. Indwelling catheters and lines.  
7. Last dose of sedation and neuromuscular blockade.  
8. What could have gone better during the procedure. 
 
 
Enhancing Awareness of the Congenital Cardiac Catheterization Lab as a Physiological 
Laboratory and a Unique High-Risk Environment 
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Although the PCCCL continues to transition from a diagnostic tool to an interventional and therapeutic 
theater, (much like an operating room), hemodynamic assessment continues to be of paramount 
importance in establishing a diagnosis and assessing the need for intervention (catheter-based or surgery). 
Awareness of the effect that anesthetic agents and ventilator strategies have on these parameters must be 
considered when planning the case. Therefore, direct communication between the cardiologist and 
anesthesiologist is mandatory and is best done prior to the patient arriving in the catheterization 
laboratory. This communication can reduce the procedural, anesthetic and radiation times, all of which 
are likely to improve patient outcomes. 
 
The Level of Cardiology Expertise Appropriate for the Pediatric and Cardiac Catheterization 
Laboratory  
 
There is no sub-specialty certification from the American Board of Pediatrics for pediatric cardiologists 
preforming catheterizations or for any other pediatric cardiology subspecialty, nor does the Accreditation 
Council for Graduate Medical Education (ACGME) recognize advanced training in catheterization. 
However, new core training requirements for pediatric cardiology recently published by the Society of 
Pediatric Cardiology Training Program Directors (SPCTPD) [26] and endorsed by the ACC, AHA, AAP 
and SCAI suggest additional training should be required for pediatric cardiologists performing these 
procedures. This suggestion is further detailed in SCAI’s 2014 expert consensus statement, 
recommending that physicians intending to perform cardiac catheterization procedures have additional 
advanced training [27].  
 
The Level of Anesthesia Expertise Appropriate for the Pediatric and Congenital Cardiac 
Catheterization Laboratory  
 
As referenced above, children with CHD are at significant risk for morbidity and mortality in the PCCCL. 
This is particularly true for infants, for patients with specific cardiac pathology, for patients with ASA 
patient status 3 or above and for patients undergoing certain transcatheter interventions. Specific 
knowledge of congenital cardiac anomalies and physiology with an applicable skill set is necessary for 
prevention and management of hemodynamic compromise and cardiac arrest in the catheterization 
laboratory. Clinicians providing moderate-to-deep sedation for patients with CHD in the catheterization 
laboratory must be prepared to manage not only the airway, but must also understand that airway 
obstruction and/or hypoventilation affects the patient’s unique physiology and could have catastrophic 
effects in patients with CHD. Clinicians must balance providing adequate sedation/anesthesia to the 
patient with the ability to anticipate, rapidly identify and appropriately respond to hemodynamic changes 
and deterioration that might require medical resuscitation, cardiopulmonary resuscitation (CPR), initiation 
of inhaled nitric oxide, treatment of massive hemorrhage and emergent cannulation into extracorporeal 
(ECMO) support. 
In 1997, pediatric anesthesiology met the criteria for recognition as a subspecialty by the ACGME, and 
the Anesthesiology Residency Review Committee developed program requirements for a 12-month 
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subspecialty fellowship training program. In 2013, the first pediatric anesthesiology subspecialty 
examination was offered by the American Board of Anesthesiologists. As with the training of pediatric 
congenital cardiologists, there is no formal ACGME-accredited fellowship training or certification 
process in pediatric congenital cardiac anesthesiology. Pediatric cardiac anesthesiology has evolved on an 
institutional basis, leading to wide discrepancies in training. At the same time, there have been significant 
advances in surgical interventions, nonsurgical interventions and medical therapies for congenital heart 
disease. These changes, along with improved outcomes, have led to surgical and nonsurgical treatments 
being offered to higher-risk patients than in the past. Pediatric cardiac anesthesiologists have played a 
pivotal role in the advancement of this care. Many tertiary care centers have pediatric cardiac 
anesthesiology divisions with members who attained expertise through a variety of training 
pathways. Due to the need for standardized and regimented training pathways to ensure high-quality care 
and continued success with the treatment of CHD, a working group from the Congenital Cardiac 
Anesthesia Society (CCAS) published a proposal for formal training in pediatric cardiac anesthesiology in 
2010 [28]. A second paper suggesting advanced second-year fellowship training in pediatric cardiac 
anesthesiology was published in 2014 [29], but no formal training has yet been developed. 
Because a limited number of academic medical centers offer advanced training or fellowship training in 
pediatric cardiac anesthesiology, there are an insufficient number of trained pediatric cardiac 
anesthesiologists to support every catheterization laboratory that cares for patients with CHD undergoing 
cardiac catheterization.  
Given the complexity of these patients, the unique environment of the cardiac catheterization laboratory 
and the limited number of pediatric cardiac anesthesiologists, who then should provide 
sedation/anesthetic care for these patients? Current manpower limitations suggest that, in many 
institutions, having pediatric cardiac anesthesiologists provide care for all patients in cardiac 
catheterization laboratories is not feasible. Given this situation, it is recommended that anesthesiologists 
involved in pediatric cardiac catheterization procedures should, as is true for cardiologists, have sufficient 
subspecialty training and experience to provide expert care. Guidelines defining sufficient training are 
evolving. Our recommendation is that the expertise of those providing anesthetic care for these patients be 
appropriate to the level of risk associated with the procedure. For higher-risk patients, care should be 
provided, at a minimum, by anesthesiologists with advanced skills and knowledge relevant to the 
pathophysiology of CHD. This knowledge must include a comprehensive understanding of the effects of 
anesthetic drugs, inotropes and respiratory interventions on the physiology specific to each congenital 
heart lesion and surgical palliation. This understanding is critical to providing a stable hemodynamic state 
that allows the accurate measurement and interpretation of the hemodynamic parameters obtained in the 
catheterization laboratory. Examples include the effects of FiO2 and pCO2 on pulmonary vascular 
resistance, changes in cardiac output associated with controlled versus spontaneous ventilation and the 
myocardial and electrophysiologic effects of anesthetics.  
 
Future Considerations 
Central to addressing patient safety in the PCCCL is the ability to prospectively stratify patients and their 
procedures to accurately predict and thereby potentially prevent or treat an adverse event during 
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catheterization. This approach is critically important for optimal planning of the appropriate resources, 
levels of expertise, and types of anesthesia or sedation required for success. Data are emerging that 
identify both patient- and procedure-specific characteristics that currently affect adverse event risks and 
therefore allow for improved planning and resource deployment. Recently, a scoring system (CRISP 
Score) has been developed that predicts the risk of a serious adverse event based on specific patient and 
procedural characteristics [30]. This scoring system assigns risk based on demographics such as age and 
weight as well as the underlying diagnosis and other concurrent systemic illnesses. In addition, the system 
assesses the potential for hemodynamic compromise by considering the need for inotropic support and the 
presence or absence of specific physiologic parameters that place a patient at higher risk. Such a tool 
could have considerable application in planning for the appropriate availability of resources, including 
anesthesia expertise. The clinical impact of such tools remains to be seen, because resource utilization 
requires careful consideration of what is needed, but also of what might be excessive.  
 
To this end, we foresee that programs might assign specific PCCCL patients and procedures to broad risk 
categories that would inform the level of resource, expertise and anesthesia or sedation strategy. For some 
select procedures and patients we can now quantify a very high potential risk for a major adverse event or 
even a catastrophic event. For example, the following patients are at increased risk: neonates who are 
candidates for PDA stent placement; neonates with single ventricular physiology; neonates with left-sided 
AV valve hypoplasia or atresia with a restrictive atrial septum, who are candidates for atrial balloon 
septostomy or stent placement; and older patients with severely calcified stenotic RV to PA conduits who 
are candidates for dilation and transcatheter valve placement. In this group of patients, maximal 
resources, expertise and an aggressive anesthesia and airway management strategy are indicated. 
Conversely, we know that some procedures have extremely low adverse event risks, such as noninfant 
ASD device closure, PDA closure >1 year or pulmonary valvuloplasty, suggesting a more modest 
allocation of resource support could be adequate. 
Although seemingly intuitive, the majority of procedures and patients lie between the extremes of this 
continuum. A critical evaluation of each patient and procedure is paramount to assessing potential risks 
and planning appropriate resources and pharmacologic management for the sedated or anesthetized 
patient. Formal pre-catheterization risk assignment tools such as the CRISP scoring system have the 
potential to structure this assessment so that resource availability can be critically evaluated with respect 
to the impact on resource allocation and associated expenses. Table 2 outlines a scheme for resource 
allocation specific to provision of sedation/anesthesia based on the CRISP scoring system. Programmatic 
management dictates that resources for reasonably anticipated adverse events be available for every 
patient. Above all, patients, not their practitioners, take risks. The patients we serve deserve no less than a 
formal assessment of the resources needed to ensure their safety and a successful outcome.  
 
Conclusion 
The care of patients with complex congenital heart disease requires multiple professionals with differing 
but interdependent skill sets. Achieving the best possible outcome requires a team approach with mutual 
respect for all involved. Knowledge of patient anatomy and physiology, the goal of the procedure, an 
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Table 1: Anesthetic Risks for Specific Patients and Procedures 
High-risk patients and procedures for anesthesia  Possible adverse events from anesthesia 
    
Williams-Beuren Syndrome  Hypotension, Coronary Ischemia, Cardiac Arrest 
 Hypertrophic Cardiomyopathy Coronary Ischemia, Cardiac Arrest 
Single-Ventricle Physiology Coronary Ischemia, Cardiac Arrest 
Aortic Valve Stenosis 
Low Cardiac Output (CO), Coronary Ischemia, 
Cardiac Arrest 
Mitral Valve Stenosis Low CO, Right Ventricular (RV) Failure 
Pulmonary Hypertension 
RV Failure, Pulmonary Hypertensive Crisis, 
Cardiac Arrest 
Pulmonary Vein Dilation  RV Failure, Pulmonary Edema, Hypoxia 
VSD Device Closure  Arrhythmia, Low CO, Cardiac Arrest 
Balloon Atrial Septostomy (newborns with single-
ventricle physiology and left AV valve hypoplasia 
or atresia) Hypoxia, Atrial Perforation, Cardiac Tamponade 
s/p Heart Transplant Ventricular Fibrillation (VF), Myocardial Ischemia 
 
Table 2: Recommended anesthesia provider expertise based on CRISP score 
CRISP Score 








0 to 1 
X   
2 to 4 
 X  
5 or greater 
  X 
1Sedation provided by non-anesthesiologists with training and certification in sedation practices 
2 Pediatric anesthesiologist with either advanced training or extensive experience in congenital cardiac anesthesia 
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